All In Biotech

Company

Cosette

Drugs filed under this Drugs@FDA sponsor name, and trials whose lead sponsor matches it. The same company may file under other names.

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

23

17 still marketed

Novel approvals

6

Approvals since 2021

3

Originals and new uses

Phase 3 trials

0

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

Drugs in development (0)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline

No investigational drugs in Phase 2 or 3 trials under this sponsor name.

Recruiting Phase 3 trials

Largest first.

No recruiting Phase 3 trials under this sponsor name.

Marketed drugs (17)

Newest FDA action first.

  • Vyleesi (Autoinjector) Bremelanotide Acetate · 2019
  • Evoxac Cevimeline Hydrochloride · 2026
  • Benicar Hct Hydrochlorothiazide, Olmesartan Medoxomil · 2003
  • Indocin Indomethacin · 1985
  • Sprix Ketorolac Tromethamine · 2010
  • Cambia Diclofenac Potassium · 2009
  • Zipsor Diclofenac Potassium · 2009
  • Sympazan Clobazam · 2018
  • Ambien Cr Zolpidem Tartrate · 2005
  • Ambien Zolpidem Tartrate · 1992
  • Welchol Colesevelam Hydrochloride · 2009
  • Welchol Colesevelam Hydrochloride · 2000
  • Effient Prasugrel Hydrochloride · 2009
  • Azor Amlodipine Besylate, Olmesartan Medoxomil · 2007
  • Tribenzor Amlodipine Besylate, Hydrochlorothiazide, Olmesartan Medoxomil · 2010
  • Benicar Olmesartan Medoxomil · 2002
  • Evoxac Cevimeline Hydrochloride · 2000

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.